Product class:
|
Medicinal product with marketing authorization
|
Medicinal product class:
|
Veterinary medicine
|
Name of medicinal product:
|
Bonqat
|
Active substances:
|
|
ATC code:
|
QN02BF02
|
Dosage form:
|
oral solution
|
Strength:
|
50mg 1ml
|
Legal status for supply*:
|
Subject to medicinal prescription
|
Summary of product characteristics (SPC):
|
|
Package information leaflet (PIL):
|
EST
|
Labelling:
|
|
Indication:
|
Alleviation of acute anxiety and fear associated with transportation and veterinary visits.
|
Safety features:
|
No
|
Marketing authorization holder:
|
Orion Corporation
|
Marketing authorization number:
|
EU/2/21/273
|
Marketing authorization issued on:
|
July 13, 2021
|
Marketing authorization expires on:
|
July 14, 2026
|
Marketing authorization procedure type:
|
Centralised
|
Assessment report:
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
1857001
|
Bonqat
|
oral solution
|
50mg 1ml 2ml 1TK
|
Prescription
|
|
|
20.12.2023
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere